definiens: : means the databases held at CTU containing data from the Centres Databases tobe used in the main analysis of the Phase III Clinical Trial ; : means the plan agreed by the Trial Steering Committee ( which will be amendedfrom time to time as required ) indicating the minimum analyses to be carried outrelating to the Phase III Clinical Trial for preparation of the Main Master File ; : means in respect of each party, the Intellectual Property Rights owned and / orControlled by that party at the Commencement Date and all Intellectual PropertyRights which that party may subsequently develop, acquire, own and/or havelicensed to it which arise outside and independently of the Programme and whichthey are free to utilise in accordance with this Agreement ; : means the clinical and non - clinical centres participating in the Programme asdetailed in Schedule 4 to this Agreement, as amended from time to time bydecision of the Programme Management Board or the Programme Liaison Group ; : means all the data which are entered onto computer from the various sources ofTrial Data at the Centres ; : means the United States Code of Federal Regulations ; : means the date of this Agreement ; : means the possession of the ability to grant a license as provided for hereinwithout violating the terms of any agreement with any third party . : means in relation to each party any information relating to such party’sBackground, business methods, suppliers, finances, ideas, strategies, concepts, methodologies, inventions, processes, specifications, marketing plans, formulaeand / or products ; : means the UK MRC Clinical Trials Unit located in London . : means current Good Manufacturing Practices to the extent applicable to Product(i ) as defined in Parts 210 and 211 of Title 21 of the CFR, as may be amended fromtime to time, or any successor thereto, and ( ii ) as required by applicable guidelinesin countries other than the United States . Firefox https://www.lawinsider.com/contracts/1FxVssTpOwdwizjwcmqH2Q/ind ..